94 related articles for article (PubMed ID: 8992683)
1. [Chronic expectoration and risk of death in chronic obstructive lung disease].
Prescott EI; Lange P; Vestbo J
Ugeskr Laeger; 1996 Nov; 158(45):6456-60. PubMed ID: 8992683
[TBL] [Abstract][Full Text] [Related]
2. Chronic mucus hypersecretion in COPD and death from pulmonary infection.
Prescott E; Lange P; Vestbo J
Eur Respir J; 1995 Aug; 8(8):1333-8. PubMed ID: 7489800
[TBL] [Abstract][Full Text] [Related]
3. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.
Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
Thorax; 1990 Aug; 45(8):579-85. PubMed ID: 2402719
[TBL] [Abstract][Full Text] [Related]
4. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
Vestbo J; Prescott E; Lange P
Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH.
Dijkstra AE; de Jong K; Boezen HM; Kromhout H; Vermeulen R; Groen HJ; Postma DS; Vonk JM
Occup Environ Med; 2014 May; 71(5):346-52. PubMed ID: 24642640
[TBL] [Abstract][Full Text] [Related]
6. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.
Peto R; Speizer FE; Cochrane AL; Moore F; Fletcher CM; Tinker CM; Higgins IT; Gray RG; Richards SM; Gilliland J; Norman-Smith B
Am Rev Respir Dis; 1983 Sep; 128(3):491-500. PubMed ID: 6614643
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.
Miravitlles M; Guerrero T; Mayordomo C; Sánchez-Agudo L; Nicolau F; Segú JL
Respiration; 2000; 67(5):495-501. PubMed ID: 11070451
[TBL] [Abstract][Full Text] [Related]
8. Potential misclassification of causes of death from COPD.
Jensen HH; Godtfredsen NS; Lange P; Vestbo J
Eur Respir J; 2006 Oct; 28(4):781-5. PubMed ID: 16807258
[TBL] [Abstract][Full Text] [Related]
9. The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.
Allinson JP; Hardy R; Donaldson GC; Shaheen SO; Kuh D; Wedzicha JA
Am J Respir Crit Care Med; 2016 Mar; 193(6):662-72. PubMed ID: 26695373
[TBL] [Abstract][Full Text] [Related]
10. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
Maestrelli P; Saetta M; Mapp CE; Fabbri LM
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472
[TBL] [Abstract][Full Text] [Related]
11. [Expectoration--an underestimated symptom?].
Vestbo J; Lange P
Ugeskr Laeger; 1993 Sep; 155(39):3100-3. PubMed ID: 8212397
[TBL] [Abstract][Full Text] [Related]
12. The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men.
Vestbo J; Knudsen KM; Rasmussen FV
Respir Med; 1989 May; 83(3):207-11. PubMed ID: 2595038
[TBL] [Abstract][Full Text] [Related]
13. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer.
Lange P; Nyboe J; Appleyard M; Jensen G; Schnohr P
Am Rev Respir Dis; 1990 Mar; 141(3):613-7. PubMed ID: 2310094
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD.
Dijkstra AE; Boezen HM; van den Berge M; Vonk JM; Hiemstra PS; Barr RG; Burkart KM; Manichaikul A; Pottinger TD; Silverman EK; Cho MH; Crapo JD; Beaty TH; Bakke P; Gulsvik A; Lomas DA; Bossé Y; Nickle DC; Paré PD; de Koning HJ; Lammers JW; Zanen P; Smolonska J; Wijmenga C; Brandsma CA; Groen HJ; Postma DS;
Eur Respir J; 2015 Jan; 45(1):60-75. PubMed ID: 25234806
[TBL] [Abstract][Full Text] [Related]
15. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.
Prescott E; Bjerg AM; Andersen PK; Lange P; Vestbo J
Eur Respir J; 1997 Apr; 10(4):822-7. PubMed ID: 9150319
[TBL] [Abstract][Full Text] [Related]
16. Relevance of airflow obstruction and mucus hypersecretion to mortality.
Wiles FJ; Hnizdo E
Respir Med; 1991 Jan; 85(1):27-35. PubMed ID: 2014356
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological studies in mucus hypersecretion.
Vestbo J
Novartis Found Symp; 2002; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485
[TBL] [Abstract][Full Text] [Related]
18. Chronic mucus hypersecretion: prevalence and risk factors in younger individuals.
Harmsen L; Thomsen SF; Ingebrigtsen T; Steffensen IE; Skadhauge LR; Kyvik KO; Backer V
Int J Tuberc Lung Dis; 2010 Aug; 14(8):1052-8. PubMed ID: 20626952
[TBL] [Abstract][Full Text] [Related]
19. Vital prognosis after hospitalization for COPD: a study of a random population sample.
Vestbo J; Prescott E; Lange P; Schnohr P; Jensen G
Respir Med; 1998 May; 92(5):772-6. PubMed ID: 9713639
[TBL] [Abstract][Full Text] [Related]
20. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
Del Donno M; Olivieri D
Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
